TCBIO vs TLRY · P/E 5.2, $3.31B cap vs rev $915.5M
Texas Capital Bancshares, Inc. (TCBIO) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Texas Capital Bancshares, Inc. (TCBIO) is a banks - regional company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
TCBIO does not have a complete income-statement cache yet.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
TCBIO currently screens at market cap $3.31B and trailing P/E 5.2. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the TCBIO and TLRY stock pages for the full models.
Not investment advice.